EPHA3 and central nervous system cancer: Ephrin type-A receptor 3 (EPHA3), a membrane-associated receptor, which is particularly overexpressed in stroma and vasculature in gliomas but not in normal tissues, can be used as a functional target for the treatment of GBM (Janes et al., 2014).